Continuous ketone monitoring, a sensor worn on the skin that tracks ketone levels in real time, may help people with certain inborn errors of metabolism, according to Gram Research analysis of a 2026 narrative review. However, the review found no direct clinical studies in these conditions yet, so the benefit remains unproven.
Gram Research analysis of a 2026 narrative review in Metabolism Open looks at whether continuous ketone monitoring could help people with certain inborn errors of metabolism, which are rare conditions present from birth that affect how the body turns food into energy. Ketones are fuel molecules the body makes when it burns fat for energy. A small sensor worn on the skin can track them in real time, something finger-prick tests cannot do easily. This technology already lowers the risk of dangerous ketone buildup in people with diabetes. The review suggests it may also help people with these rare disorders, including those on ketogenic diets, by catching early warning signs of metabolic crisis. However, the authors found no direct clinical studies testing it in these conditions yet, so the benefit remains a possibility rather than a proven result.
Key Statistics
A 2026 narrative review published in Metabolism Open found that continuous ketone monitoring has been shown to reduce the risk of diabetic ketoacidosis in diabetes care but has no direct clinical trial evidence yet in inborn errors of metabolism.
According to a 2026 narrative review in Metabolism Open, continuous ketone monitoring may help catch early signs of metabolic decompensation in people with rare inherited metabolic disorders, although the review did not report a sample size because it summarized existing research rather than enrolling participants.
The Quick Take
- What they studied: The researchers asked whether a sensor that continuously measures ketones under the skin could be useful for people with rare inherited metabolic disorders, not just people with diabetes.
- Who participated: No participants were enrolled. This was a review of existing research and expert knowledge, so there was no sample of people to describe.
- Key finding: The review found that continuous ketone monitoring is well supported in diabetes care but has not yet been tested directly in rare metabolic disorders. Its possible benefits in those conditions are based on reasoning, not on clinical trial results.
- What it means for you: If you or a family member has a rare metabolic condition, this technology may become a useful tool in the future. For now, it is still experimental for these conditions, so any use should be guided by your medical team.
The Research Details
This was a narrative review, which means the authors looked at the existing body of knowledge and discussed it in a structured way. It is not a new experiment. The authors examined what is known about ketones, how they are involved in certain inherited metabolic disorders, and why current ways of checking ketones have limits.
The review compared traditional ketone checks, such as urine strips and blood finger-prick tests, with newer continuous sensors. Traditional checks are often inconvenient and provide only a snapshot in time. Continuous sensors measure a fuel molecule called beta-hydroxybutyrate in the fluid just under the skin, giving a running picture of how ketone levels change over hours and days.
The authors also described the rare conditions where ketone control matters, such as disorders of ketone breakdown and metabolic conditions treated with ketogenic diets. They then considered how sensors could help in these areas, based on what is already known from diabetes care and on the known vulnerabilities of these patients.
A narrative review is useful for exploring a new idea before large studies are done. It helps researchers and doctors see where the technology might fit, which questions still need answers, and which studies should be designed next. For a topic with almost no direct clinical data, this kind of overview is an important first step.
The approach also has limits. Because a narrative review does not follow a strict, pre-set method for choosing and scoring studies, its conclusions depend on the authors’ judgment. Readers should treat its suggestions as hypotheses to be tested rather than established facts.
The paper is published in a peer-reviewed journal, which means outside experts reviewed it before publication. Its main strength is its clear statement that direct evidence is lacking. The authors do not overstate what they found. The weakness is that a narrative review cannot prove that the sensor works in rare metabolic disorders, and it reports no new patient data. The reliability of its ideas will depend on the studies that follow.
What the Results Show
The review’s main point is that continuous ketone monitoring is a promising tool that has not yet been proven in rare inherited metabolic disorders. In diabetes, where the technology has the most evidence, it helps reduce the risk of diabetic ketoacidosis, a dangerous condition in which ketones build up to harmful levels in the blood. It also appears to reduce hospital visits and healthcare costs.
The authors suggest several possible uses in rare disorders. In disorders of ketone breakdown, the sensor could help doctors and families see how the body handles ketones over time and adjust treatment to better control metabolism. For people on ketogenic diets, which are high in fat and low in carbohydrates, continuous tracking may help guide decisions about seizure control and prevent complications.
The review also proposes that sensors could catch early signs of a catabolic state, which is when the body breaks down its own tissue for energy, often during illness, fasting, or stress. Early detection could allow faster treatment before a metabolic crisis develops. The authors also suggest sensors could improve monitoring for ketone problems in people with rare disorders who also have insulin deficiency.
The review points out that traditional ketone checks are impractical for long-term use and provide little information about patterns. This gap is one reason the authors believe continuous monitoring could add value. A sensor that tracks trends can show when levels are rising, falling, or staying stable, which a single reading cannot do.
The authors also note that these disorders are often unpredictable in their effects on different people. Because each person’s metabolic needs can differ, real-time information could help tailor care more closely. However, this idea is still a theory that needs testing.
The strongest existing evidence for continuous ketone monitoring comes from diabetes care, where studies have linked it to fewer cases of diabetic ketoacidosis, fewer hospital stays, and lower healthcare costs. This review builds on that work by asking whether the same approach can work for a different group of patients. It is one of the first papers to explore this idea in inborn errors of metabolism, so it breaks new ground rather than confirming earlier results in the same population.
The most important limitation is that the review found no direct clinical studies testing continuous ketone monitoring in inborn errors of metabolism. Every suggested benefit is a reasoned possibility. The review also did not include new patient data, so it cannot show how well the sensors perform in these specific conditions.
As a narrative review, the paper does not use a strict system for finding and grading all relevant studies, so its selection of evidence reflects the authors’ judgment. Sensor accuracy in these populations, the effect of diet and illness on sensor readings, and the cost and availability of the devices were not addressed in detail. These gaps must be filled before the technology can be recommended with confidence.
The Bottom Line
Confidence is currently low for using continuous ketone monitoring in rare inherited metabolic disorders, because no direct clinical trials have tested it there yet. Confidence is higher for its use in diabetes, where research has shown reduced ketoacidosis risk. Families and clinicians may want to discuss the technology with a metabolic specialist, but they should not change treatment based on this review alone. Future clinical studies are needed before firm recommendations can be made.
People with rare inherited metabolic disorders, their families, and the clinicians who manage their care should follow this research. Researchers designing new studies will find it especially useful. People without these conditions and without diabetes are unlikely to benefit from this specific application, and they should not assume the findings apply to them.
Because the idea is still at an early stage, meaningful clinical results are likely to take several years. Studies must be designed, funded, and completed before doctors can know whether sensors improve outcomes in these conditions. Any benefit would likely appear gradually as research and clinical experience build up.
Frequently Asked Questions
What is continuous ketone monitoring and how does it work?
Continuous ketone monitoring uses a small sensor worn on the skin to measure beta-hydroxybutyrate, a ketone, in the fluid just under the skin. Unlike finger-prick tests, it shows how ketone levels change over hours and days, giving a running picture rather than a single snapshot.
Can continuous ketone monitoring help people with rare metabolic disorders?
A 2026 narrative review in Metabolism Open suggests it may help, particularly for people on ketogenic diets or with disorders of ketone breakdown. However, the review found no direct clinical trials testing it in these conditions yet, so the benefit is still a possibility.
Does continuous ketone monitoring prevent diabetic ketoacidosis?
Research in diabetes care shows that continuous ketone monitoring reduces the risk of diabetic ketoacidosis, a dangerous buildup of ketones in the blood. It may also reduce hospitalizations and healthcare costs, according to the review’s summary of existing evidence.
What are inborn errors of metabolism?
Inborn errors of metabolism are rare conditions present from birth in which the body cannot process certain nutrients or fuel molecules properly. They can affect energy levels, brain function, and growth, and they often require lifelong dietary or medical management.
Want to Apply This Research?
- If you use a continuous ketone sensor under medical guidance, log your readings at the same times each day, along with meals, activity, illness, and any symptoms. Note any readings your care team has said to watch closely. Consistent logging makes it easier to spot patterns and share useful information during appointments.
- Use the app to set reminders for scheduled checks and to flag readings outside the range your care team has given you. Encourage yourself to review trends weekly rather than reacting to every single number. Always follow the action plan your medical team has provided for high or low readings.
- Over the long term, track trends in ketone levels alongside seizure frequency, energy levels, appetite, and any hospital visits. Share summaries with your metabolic team regularly. Review the data every few months to see whether the sensor is helping and whether your care plan needs adjusting. Update your approach as new research is published.
This article summarizes a narrative review that proposes possible uses of continuous ketone monitoring in rare inherited metabolic disorders. The review does not provide new clinical evidence for these uses. This information is for general education only and is not medical advice. Anyone with a metabolic condition, or who is considering ketone monitoring, should consult a qualified metabolic specialist or physician before making any changes to diet, medication, or monitoring.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.